Remove 2025 Remove IPO Remove Public Trading
article thumbnail

D. Boral Capital Served as the Sole Underwriter on the IPO of BurTech Acquisition Corp (Nasdaq: BRKH) which Recently Completed an ~$894 Million Business Combination with Blaize, Inc. (“Blaize”)

Global Newswire by Notified: M&A

15, 2025 (GLOBE NEWSWIRE) -- BurTech Acquisition Corp. BurTech) (NASDAQ: BRKH), a publicly traded special purpose acquisition company, and Blaize, Inc. and began trading on Nasdaq under the ticker symbols BZAI and BZAIW on January 14, 2025. WASHINGTON and EL DORADO HILLS, Calif.,

article thumbnail

10-23-2023 Newsletter: Why Take-Private Dealmaking Remains Attractive for PE Investors

OfficeHours

First, private equity identifies the publicly traded company they believe is undervalued or could perform better as a private entity without the pressures of being a public entity (e.g. After a certain period of time, usually 5-7 years, the PE firm will look to exit the investment.

Investors 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

billion kicking off 2025 with a bang, will the pounds go back on in the new year? Below we take a look at drivers of these dynamics over the past year and offer our predictions for whats to come in 2025. With J&Js announced deal to acquire Intra-Cellular Therapies for $14.6

M&A 64
article thumbnail

Momentum Builds for Ophthalmology Recapitalizations

Focus Investment Banking

Traditional terminal exit routes for private equity-backed companies are to larger strategic acquirers (often public companies) and IPOs, where a private company becomes publicly traded. It is also likely that IPOs will come to PPM, perhaps first to those specialties with the largest assets (e.g.,